A Case of Psoriasis Complicated by Breast Cancer after Systemic Treatments Including Biologics

被引：0

作者：

Morizane, Shin ^{[1
]}

Sugimoto, Saeko ^{[1
]}

Motoki, Takayuki ^{[2
]}

Katayama, Norihisa ^{[3
]}

Omori, Masako ^{[4
]}

Iwatsuki, Keiji ^{[1
]}

机构：

[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dermatol, Okayama 7008558, Japan

[2] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Breast & Endocrinol Surg, Okayama 7008558, Japan

[3] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Radiol, Okayama 7008558, Japan

[4] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama 7008558, Japan

来源：

ACTA MEDICA OKAYAMA | 2018年 / 72卷 / 02期

关键词：

psoriasis; systemic therapy; biologics; malignancy; POPULATION-BASED COHORT; RISK; CYCLOSPORINE; DISEASE;

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Psoriasis is a common chronic inflammatory skin disorder that is characterized by scaly, erythematous, sharply demarcated plaques. The treatment for psoriasis has dramatically changed over the last 10 years with the introduction of biologics. However, the risk of cancer induced by biologics for psoriasis has not been fully analyzed, since these agents have such a short history of use. Here we report the case of a 74-year-old woman with psoriasis vulgaris and psoriatic arthritis complicated by breast cancer after systemic treatments including etretinate, cyclosporine, methotrexate, adalimumab, and ustekinumab.

引用

页码：185 / 187

页数：3

共 18 条

[1]

Ali FR, 2017, NEW ENGL J MED, V376, P2095, DOI 10.1056/NEJMc1704342

[2] HLA-DRB1*15:01 and Epstein-Barr virus in a multiple sclerosis patient with psoriasis, nasopharyngeal and breast cancers. Lessons for possible hidden links for autoimmunity and cancer [J].

Anagnostouli, Maria ;

Anagnostoulis, Georgios ;

Katsavos, Serafeim ;

Panagiotou, Maria ;

Kararizou, Evangelia ;

Davaki, Panagiota .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 339 (1-2) :26-31

[3]

Asgari MM, 2017, J AM ACAD DERMATOL

[4] Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden [J].

Boffetta, P ;

Gridley, G ;

Lindelöf, B .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (06) :1531-1537

[5] Study of eight cases of cancer in 426 rheumatoid arthritis patients treated with methotrexate [J].

Bologna, C ;

Picot, MC ;

Jorgensen, C ;

Viu, P ;

Verdier, R ;

Sany, J .

ANNALS OF THE RHEUMATIC DISEASES, 1997, 56 (02) :97-102

[6] Psoriasis and Risk of Incident Cancer: An Inception Cohort Study with a Nested Case-Control Analysis [J].

Brauchli, Yolanda B. ;

Jick, Susan S. ;

Miret, Montserrat ;

Meier, Christoph R. .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (11) :2604-2612

[7] THE RISK OF NEOPLASMS IN PATIENTS TREATED WITH CYCLOSPORINE-A [J].

COCKBURN, ITR ;

KRUPP, P .

JOURNAL OF AUTOIMMUNITY, 1989, 2 (05) :723-731

[8] Koebnerized psoriasis masquerading as recurrent breast cancer [J].

Collin, B ;

Zaki, I .

CLINICAL ONCOLOGY, 2003, 15 (08) :506-506

[9] The Risk of Cancer in Patients With Psoriasis A Population-Based Cohort Study in the Health Improvement Network [J].

Fuxench, Zelma C. Chiesa ;

Shin, Daniel B. ;

Beatty, Alexis Ogdie ;

Gelfand, Joel M. .

JAMA DERMATOLOGY, 2016, 152 (03) :282-290

[10] THE PREVALENCE OF MALIGNANT-TUMORS IN PATIENTS WITH PSORIASIS [J].

LINDELOF, B ;

EKLUND, G ;

LIDEN, S ;

STERN, RS .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1990, 22 (06) :1056-1060

← 1 2 →